Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Helicobacter Infections

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Helicobacter Infections in 1 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Slomiany, BL1
Slomiany, A1

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Helicobacter Infections

ArticleYear
Platelet-activating factor mediates Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis.
    IUBMB life, 2004, Volume: 56, Issue:1

    Topics: Amidines; Androstadienes; Animals; Benzylamines; Enzyme Inhibitors; Gastric Mucins; Gastric Mucosa;

2004